Yangchao Chen School of Biomedical Sciences Faculty of Medicine The Chinese University of Hong Kong Shatin Hong Kong Biography
Biography of Yangchao Chen
He is a Principal Investigator at Cancer Biology & Experimental Therapeutics Theme,
School of Biomedical Sciences, CUHK. He is also the Principal Investigator at
Shenzhen Research Institute, CUHK at Shenzhen. He is actively involved in molecular
biology of pancreatic cancer and liver cancer. He is also an active reviewer of
multiple grant agencies and peer-reviewed journals.
Simone Mocelin University of Padova Padova Italy Biography
Biography of Simone Mocelin
Dr. Simone Mocelin obtained Doctorate in Oncology and Surgical Oncology from the University of Padova Italy. Dr. Mocelin is presently serving as an Associate Professor of Surgery and Gastroenterology in the same University and he is also a Surgeon at the Surgical Oncology Unit. He has contributed more the 250 Publications having citation around 9110. He is a member of the editorial board of several international peer-review medical journals and is an editor of the Cochrane Colorectal Cancer Group.
D. Santini University Campus Bio-Medico Rome Italy Biography
Biography of D. Santini
Prof. Daniele Santini obtained the PhD in Immunophysiology at the University of Palermo. He has been Associate Professor of General Pathology at the Campus Bio-Medical University and Head of the Oncologic Day Hospital's Simple Operational Unit (UOS) at the Politecnico Universitario Campus Bio-Medico in Rome. As Co-Head of the Laboratory of Transnational Oncology, he leads numerous preclinical and translational studies with the collaboration of his staff. He is a member of many scientific societies (AIOM, ISO, ESMO GOIM, etc). He is an effective member of the Editorial Board and a reviewer of papers of some international scientific journals. He is author of over 300 publications in national and international scientific journals featuring impact factors.
Frontiers Section Editor
Section: Craniofacial Pathobiology
J. Schwartz University of Illinois Chicago, IL USA Biography
Biography of J. Schwartz
I obtained my training for Oral Maxillofacial Pathology at Harvard School of Medicine and Dana –Farber Cancer Center and I am presently Director of Oral Maxillofacial Pathology Research at the College of Dentistry, University of Illinois. My first studies focused on viral carcinogenesis and immune regulation. Since the 1970s we reported early detection and prevention of oral cancer can be influenced by diet and molecular pathways that regulate epithelial cell growth and differentiation. These associations are examined through animal models to study mucosa responses to carcinogens and immunology and epithelial biology of normal and tumorigenic cells, cell lines.
Editorial Board Members
R.J. Ablin University of Arizona College of Medicine Arizona, AZ USA Biography
Biography of R.J. Ablin
Dr. Ablin is a Professor at University of Arizona College of Medicine, Arizona Cancer Center and BIO5 Institute and President, Robert Benjamin Ablin Foundation for Cancer Research, founded in memory of his father. He was honored as recipient of the First Award for Scientific Excellence. He discovered prostate-specific antigen (PSA), and was a nominee for the Lasker Award. He is a pioneer of cryosurgery and the concept of “cryoimmunotherapy” for the treatment of cancer. He is a member of Sigma Xi, Phi Beta Kappa and numerous professional societies. He has been an invited speaker, contributed numerous articles, co-editor of the book series Cancer Metastasis -Biology and Treatment and serves on the editorial board of several journals.
J.M. Argiles Universidad de Barcelona Barcelona Spain Biography
Biography of J.M. Argiles
Professor Josep M. Argiles was born in Barcelona, Catalonia, Spain in 1956 and completed his undergraduate studies in Biology at the University of Barcelona graduating with a First Class Honours Degree and Special Prize for the best B.Sc. (1979). In 1981 he received his Doctorate in Biochemistry from the same university with Cum Laude obtaining the Prize for the best doctorate of that year. In 1987 he undertook further postdoctoral training in the Laboratory of Metabolism and Molecular Biology at the National Institutes of Health, Bethesda, Maryland. He later became Full Professor of Biochemistry and Molecular Biology of Cancer at the Faculty of Biology, University of Barcelona being the leader of a research group interested in cancer cachexia.
D. Assimakopoulos University of Ioannina Ioannina Greece
A.V. Bakin Roswell Park Cancer Institute Buffalo, NY USA Biography
Biography of A.V. Bakin
Dr. Andrei V. Bakin obtained his Ph.D. degree (1990) in Molecular Biology from Moscow State University, Moscow, Russia. Since 2003, Dr. Bakin has been Associate/Assistant Professor of Oncology at Roswell Park Cancer Institute, Buffalo, NY, USA. Additionally, since 2014, he has also been performing the role of Research Associate/Assistant Professor, State University of New York (SUNY) at Buffalo, Buffalo, NY, USA. Dr. Bakin, as an author/co-author, has published more than 50 articles in various journals, having a noteworthy number of total citations, i.e. over 5,000. His professional memberships include the following: American Association for Cancer Research (AACR) (1996-present), Metastasis Research Society (2004-present), American Society for Cell Biology (2004-present), and Tumor Microenvironment Society (2006-present).
M. Bar-Eli University of Texas MD Anderson Cancer Center Houston, TX USA
J.R. Bertino UMDNJ-Robert Wood Johnson Medical School New Brunswick, NJ USA Biography
Biography of J.R. Bertino
Joseph R. Bertino, MD, is Professor at UMDNJ-Robert Wood Johnson Medical School and director of the school's Cancer Institute of New Jersey Bertino in New Brunswick. He has been internationally recognized for his role in finding curative treatments for leukemia and lymphoma. During his academic career, He received several awards and honors for his research accomplishments. Currently, he is the associate editor for Cancer Research and Clinical Cancer Research and also the editor of the Encyclopedia of Cancer. He is the author and co-author of more than 400 scientific publications. His research elucidated the mechanisms of methotrexate resistance in experimental models, and in cancer patients.
M.C. Botelho National Institute of Health Porto Portugal Biography
Biography of M.C. Botelho
Monica C. Botelho has completed her Ph.D with Distinction in 2011 from the Faculty of Medicine of Porto University. She is the Head of Lab of Health Promotion and Chronic Diseases Unit of the National Institute of Health (INSA) Dr. Ricardo Jorge, a premier health service organization in Porto, Portugal and Researcher at Instituto of Investigação e Inovação em Saúde (i3S), Group of Metabolism, Nutrition and Endocrinology, of Porto University, Portugal. She has published more than 50 papers and has an H Index of 17 (Google Scholar metrics). Her areas of expertise include: Neglected Tropical Diseases associated Cancers and Infertility, Molecular carcinogenesis of schistosome associated squamous cell carcinoma of the bladder with mouse experiments as models of carcinogenesis, Effects of schistosoma-derived estrogenic molecules on cell lines and the accumulation and biodistribution of these molecules in animal models, and their possible carcinogenic effect and Schistosomiasis associated catechol-estrogens as biomarkers of cancer and infertility.
E. Bouffet The Hospital for Sick Children Toronto, ON Canada Biography
Biography of E. Bouffet
Dr. Eric Bouffet is Professor of Paediatrics in the University of Toronto, Garron Family Chair in Childhood Cancer Research, Associate Senoior Scientist at the Research Institute, and Head of the Neuro-oncology Section in the Division of Haematology/Oncology at The Hospital for Sick Children, Toronto. His research interests are in the area of novel treatments and clinical trials in children with brain tumours. He is author or co-author of over 380 peer-reviewed manuscripts and author/co-author on numerous book chapters in the field of neuro-oncology.. In 2016, he became the President of the International Society of Paediatric Oncology (SIOP).
R.M. Bukowski Cleveland Clinic Taussig Cancer Center Cleveland, OH USA Biography
Biography of R.M. Bukowski
Dr. Bukowski is an emeritus staff at the Cleveland Clinic Foundation, and was recently the Deputy Director of the Cleveland Clinic Taussig Cancer Center and Director of the Experimental Therapeutics at the Cleveland Clinic Cancer Center. He held the James Zito Chair in Cancer Research at the Taussig Cancer Center from 2001 to 2008. Dr. Bukowski is a fellow of the American College of Physicians and a member of numerous professional societies, including the American Society of Clinical Oncology, and the American Society of Hematology. He is a lifelong researcher with interests in immunotherapy, the immunology and biology of renal cell carcinoma, and new drug development and investigation. Currently Dr. Bukowski is a member of the board of directors of the Kidney Cancer Association, & its medical committee.
J. Cai Duke University Medical Center Durham, NC USA Biography
Biography of J. Cai
Dr. Cai is an ABR certified medical physicist and an Associate Professor of Radiation Oncology at Duke University Medical Center. Dr. Cai has published more than 60 peer-reviewed journal articles and over 190 conference abstracts. Dr. Cai’s research is mainly focused on developing and clinically implementing novel imaged guided radiation therapy techniques, with an emphasis on MRI. Dr. Cai regularly provides scientific reviews for peer-reviewed journals, conferences, and grant applications. His research has received federal, charitable, and industrial funding. Dr. Cai actively practice all aspects of clinical radiation physics, including treatment planning, quality control, brachytherapy, and stereotactic-body radiotherapy.
G. Carruba ARNAS-Civico Palermo Italy
R.J.F. Catarino Hospital Pedro Hispano Matosinhos Portugal Biography
Biography of R.J.F. Catarino
Dr. Raquel Catarino is a researcher in the Molecular Oncology Unit, Portuguese Institute of Oncology Francisco Gentil Porto, Portugal. She completed her Medical degree in 2013 and is a Medical Resident in Urology at Pedro Hispano Hospital. She completed her PhD in Biomedical Sciences in 2007 and a post-doctoral fellowship (2013) at Sackler Faculty of Medicine, University of Tel-Aviv, Israel. She has published more than 50 papers in scientific journals in the field of molecular oncology and pharmacogenomics.
E. Choy Harvard Medical School Boston, MA USA Biography
Biography of E. Choy
Dr. Choy is the Director of Sarcoma Research at the Division of Hematology Oncology at MGH and Assistant Professor in Medicine at Harvard Medical School. He specialized in the medical management of patients with sarcomas, gastrointestinal stromal tumors, chordomas, and desmoid tumors. He works closely with a team of world class surgical, orthopedic, and radiation oncologists as well as connective tissue pathologists and radiologists to provide optimal care for his patients. He directs a clinical trials program at the MGH Center for Sarcoma and Connective Tissue Oncology that includes 9-12 active phase I-III clinical trials.
R. Clarke Georgetown University Medical Center Washington, DC USA Biography
Biography of R. Clarke
Robert Clarke, Ph.D., D.Sc. leads Georgetown University Medical Center’s high performance research community, expanding its extramural funding and promoting the efforts of its faculty. Also, he works in collaboration with the Georgetown University Graduate School of Arts and Sciences to cultivate and strengthen the research components of the University’s graduate programs and the quality of graduate biomedical education. Clarke is co-director of the Georgetown-Lombardi Comprehensive Cancer Center breast cancer program, a professor in the Department of Oncology, and an internationally known breast cancer researcher.
K.A Cooney University of Utah School of Medicine Salt Lake City, MI USA Biography
Biography of K.A Cooney
Kathleen A. Cooney, MD, is Professor and Chair of the Department of Internal Medicine, H.A. and Edna Benning Presidential Endowed Chair, at the University of Utah. She received her M.D. degree from the University of Pennsylvania Perelman School of Medicine at Philadelphia in 1984. Her research led to the important discovery of a recurrent mutation in the HOXB13 gene that increases the chances of being diagnosed with prostate cancer. As an oncologist, Cooney focuses on treating advanced forms of prostate cancer.
J.M. Daly Temple University School of Medicine Philadelphia, PA USA Biography
Biography of J.M. Daly
Dr. John M. Daly was Dean of the School of Medicine at Temple University from 2002 to 2011. Prior to that, he had been the Stimson Professor and Chairman of the Department of Surgery at the New York Presbyterian-Cornell Medical Center in New York City since 1993. He was previously Professor of Surgery and Chief of the Division of Surgical Oncology at the University of Pennsylvania. Dr. Daly is an internationally renowned surgeon whose clinical work and research are in the fields of surgical oncology, metabolism, and nutrition, authoring more than 300 peer-reviewed publications and 100 book chapters. He has served on the editorial boards of dozens of medical publications.
D.N. Danforth, Jr Center for Cancer Research, National Cancer Institute Bethesda, MD USA Biography
Biography of D.N. Danforth
Dr. Danforth received his M.S. degree in physiology from the University of New Mexico, Albuquerque, NM and M.D. degree from Northwestern University, Chicago IL. He received his residency training in general surgery at the New York Hospital-Cornell medical Center in NYC, and received fellowship training in surgical oncology at the National Cancer Institute, NIH, Bethesda, MD, and the M.D. Anderson Hospital and Tumor Institute, Houston TX. He is a Staff Clinician in the Surgery Branch, National Cancer Institute, NIH, Bethesda. He has published more than 100 scientific publications in peer-reviewed journals.
L. Dubeau University of Southern California, Keck School of Medicine Los Angeles, CA USA Biography
Biography of L. Dubeau
Louis Dubeau received his M.D.C.M. in 1979 and his Ph.D. in biochemistry in 1981, both from McGill University in Canada. He moved to University of Southern California in 1985 to study cancer biology and epigenetics under the sponsorship of Dr. Peter Jones. He became assistant professor in the Department of Pathology at University of Southern California in 1989, where he is currently Professor of Pathology and Medical Director of Molecular Pathology. His research is focused on the biology of ovarian carcinoma. Significant contributions include our understanding of the site of origin of these tumors and of the mechanisms underlying their hormonal and genetic risk factors.
W.S. El-Deiry University of Pennsylvania Philadelphia, PA USA Biography
Biography of W.S. El-Deiry
Wafik El-Deiry, MD, PhD, FACP is the Deputy Cancer Center Director for Translational Research, co-Leader of the Molecular Therapeutics Program, Professor of Oncology, and the William Wikoff Smith Endowed Chair in Cancer Research at Fox Chase Cancer Center in Philadelphia. He earned MD/PhD degrees from University of Miami School of Medicine and completed internal medicine residency and medical oncology fellowship at Johns Hopkins. He discovered cyclin-dependent kinase (CDK) inhibitor p21(WAF1) as a p53 target gene and cell cycle inhibitor. This is the most highly cited original work published in Cell. He has >350 peer-reviewed publications and edited 5 books. He is an elected member of the Johns Hopkins University Society of Scholars.
J.M. Ford Stanford University Stanford, CA USA Biography
Biography of J.M. Ford
Dr. Ford is a medical oncologist and geneticist at Stanford, devoted to studying the genetic basis of breast and GI cancer development, treatment and prevention. He received his M.D. degree from the School of Medicine in 1989. He is currently Professor of Medicine (Oncology) and Genetics, and Director of the Stanford Cancer Genetics Clinic and the Cancer Genomics Program at the Stanford University Medical Center. His clinical interests include the diagnosis and treatment of patients with a hereditary pre-disposition to cancer. He is an editor of numerous scientific journals, including Cancer Research, DNA Repair, and PLoS Genetics. He has recently been named the founding Editor-in-Chief of JCO Precision Oncology.
H.S. Friedman Duke University Medical Center Durham, NC USA Biography
Biography of H.S. Friedman
Dr. Henry S. Friedman is an internationally renowned academic adult and pediatric neuro-oncologist who helps to lead The Preston Robert Tisch Brain Tumor Center at Duke University. He is the author of more than 500 peer reviewed articles, reviews, and book chapters and has presented extensively at both international and national meetings. He is the senior editor of CNS Oncology, was the Associate Editor for the Neuro-Oncology Section of Cancer for 15 years and is a reviewer for over 25 academic journals.
M.D. Galigniana University of Buenos Aires Buenos Aires Argentina Biography
Biography of M.D. Galigniana
We study the biological role of two Hsp90-binding immunophilins, FKBP51 and FKBP52. We have postulated a novel model for the mechanism of action of steroid receptors, where FKBP52 links the receptor-Hsp90 complex to motor proteins favouring receptor retrotransport on cytoskeletal tracts, its passage through the nuclear pore and transcriptional activation. FKBP51 antagonizes these effects. The model was extended to other factors (HSF1, p53, NF-kB) and proposes that the FKBP52/FKBP51 expression ratio regulates the final biological response of factors with pleiotropic action. We have also demonstrated that both immunophilins regulate neurodifferentiation, and have identified FKBP51 as a novel mitochondrial factor. It shows antiapoptotic action, is overexpressed in tumor cells and enhances telomerase activity.
A.J. Giaccia Stanford University Stanford, CA USA Biography
Biography of A.J. Giaccia
Dr. Amato J. Giaccia obtained his Ph.D. in Pathology/Molecular Biology from the University of Pennsylvania in Philadelphia. He is a Professor of Radiation Oncology, Associate Chair for Research & Director of the Division of Radiation & Cancer Biology in the Department of Radiation Oncology. He also is the Director of Basic Science at the Stanford Cancer Institute and heads the Radiation Biology Program in Stanford’s Cancer Center. He co-authored the sixth & seventh editions of the textbook, “Radiation Biology for the Radiologist,” with Professor Eric Hall from Columbia. In addition, he is currently the “Jack, Lulu and Sam Willson Professor in Cancer Biology” in the Stanford University School of Medicine.
R. Giavazzi IRCCS-Mario Negri Institute for Pharmacological Research Milan Italy Biography
Biography of R. Giavazzi
Dr Raffaella Giavazzi obtained a doctorate (PhD) in Pharmacology from the University of Milan, Italy. She holds the Qualification of Professor in General Pathology and in Applied Biology. She was a post-doc Fellow at NCI-FCRDC, Frederick, (USA) and Assistant Professor at MD Anderson Hospital, Houston (USA).
Currently Dr Giavazzi is Head of the Laboratory of Biology and Treatment of Metastasis at the Mario Negri Institute for Pharmacological Research and she is in the Board of Directors at the University of Trento, Italy.
She has published approximately 200 articles in the field of Cancer Research and communicated approximately 400 studies in national and international congresses.
E. Grassilli University of Milano-¬Bicocca Monza Itlay Biography
Biography of E. Grassilli
Dr. Grassilli received her Ph.D. degree from the University of Modena, Italy, and pursued her post-doctoral research at Thomas Jefferson University, Philadelphia and European Institute of Oncology, Milan, studying the molecular mechanisms of apoptosis and their relevance in the response to chemotherapy. More recently, she co-founded Bionsil, a spin-off of the University of Milano-Bicocca, Italy, aimed at identifying and characterizing novel targets for molecular diagnosis and therapy of drug-resistant cancers. From 2014 she is Assistant Professor at the University of Milano-Bicocca where she continues her work on p65BTK, a novel Bruton’s Tyrosine isoform previously identified as a new target of therapy in colon cancers.
H.-H Hann Thomas Jefferson University Hospital Philadelphia, PA USA Biography
Biography of H.-H Hann
Following Oncology Fellowship at Sidney Farber Cancer Institute, she joined Baruch Blumberg, the Nobel Laureate for discovery of HBV, at Fox Chase Cancer Center and worked on HBV, HCC, cancer enhancing effects of iron and anti-tumor effect of deferoxamine. Her new discovery included serum ferritin as the tumor and prognostic marker for neuroblastoma. Since 1988 she as the tenured Professor of Medicine and Director of Liver Disease Prevention Center at Thomas Jefferson University Hospital, has continued work on HBV as the Site Principal Investigator of 32 clinical trials evaluating anti-HBV agents (Lamivudine, Adefovir, Telbivudine, Entecavir, Tenofovir and TAF(Tenofovir alafenamide).
R. Haq Dana-Farber Cancer Institute Boston, MA USA Biography
Biography of R. Haq
Dr. Haq is a physician-scientist who specializes in metastatic melanoma. He received his MD and PhD at the University of Toronto and the Ontario Cancer Institute with various honors. His internal medicine training was in the Osler Housestaff Training Program at Johns Hopkins Hospital, followed by fellowship training in oncology at Dana-Farber/Harvard Cancer Care. At the completion of his clinical training, he was a post-doctoral fellow with Dr David E. Fisher (Massachusetts General Hospital). He has been a contributing author of numerous publications, including those published in Cancer Cell, Nature, Proceedings of the National Academy of Sciences USA. At Dana-Farber Cancer Institute, devotes part of his time to developing the next generation of melanoma therapeutics and translating them to innovative investigator-initiated clinical trials. His clinical practice is dedicated to patients with melanoma.
D. Ilson Memorial Sloan-Kettering Cancer Center New York, NY USA Biography
Biography of D. Ilson
Dr. Ilson is attending physician and member at Memorial Hospital, and professor of medicine at Weill-Cornell Medical College. His research interest is upper gastrointestinal cancer with a focus on esophageal cancer. His research focuses on the study of new agents in advanced esophageal cancer and in combined modality therapy. He sits on U.S. NCCN Gastric Cancer guideline panel, and the GI Cancer committees of Alliance/CALGB and NRG/RTOG. He is the former chair of the U.S. NCI Esophageal and Gastric Cancers Clinical Trial Task Force.
M.D. Incalci Istituto di Ricerche Farmacologiche Mario Negri Milan Italy Biography
Biography of M.D. Incalci
Maurizio D'Incalci obtained his Medical Degree cum Laude from the University of Milan (1978). Then he specialized in Pharmacology (1979) and in Oncology (1981). He worked in the Molecular Pharmacology Laboratory, NCI, Bethesda (1983-84). He is chief of the Cancer Chemotherapy Laboratory (since 1986) and of the Oncology Department (since 1996) at the Mario Negri Institute. He has been member of the board of several National and International organizations as EORTC, SENDO, SIC and he’s currently member of AIRC, MaNGO, Fondazione Mattioli, Fondazione Buzzi. He is author of more than 500 papers on cancer pharmacology and of several book chapters.
E. Iorio Istituto Superiore di Sanità Roma Italy Biography
Biography of E. Iorio
Dr Egidio Iorio is a Researcher of Department of Cell Biology and Neurosciences at the Istituto Superiore di Sanità (Rome- Italy). Master Degree in Biological Sciences and Specialization in Clinical Pathology at University of Rome "La Sapienza". PhD in Biochemistry and Molecular Biology at University of Rome "Tor Vergata". The main research interests of Dr Iorio were focused on alterations in metabolism in relation to cell differentiation, tumor growth and cell death. He is actively involved in projects to develop original molecular imaging methods for the identifications of magnetic resonance spectroscopy biomarkers of tumour cell proliferation and response to therapy.
Y. Ito Kuma Hospital Kobe Japan
B. Kaina University Medical Center Mainz Germany Biography
Biography of B. Kaina
Dr. Bernd Kaina obtained his Ph.D. in genetics in 1976 from the Universtity of Halle, Germany. He completed his postdoctoral training at the Institute of Genetics in Gatersleben and continued his studies on DNA repair at the Department of Molecular Biology in Leiden, Netherlands, at the German Cancer Research Center in Heidelberg and, as a Heisenberg fellow, at the Department of Genetics of the Nuclear Research Center in Karlsruhe, Germany. In 1993 he was appointed full professor for molecular toxicology at the Institute of Toxicology of the University of Mainz, where he is since 2003, director of the institute. He is author of more than 280 scientific publications and serves as editorial board member and reviewer for several scientific journals.
R. Kalluri Harvard University School of Medicine Boston, MA USA
D.V. Krysko Ghent University Ghent Belgium Biography
Biography of D.V. Krysko
Dmitri V. Krysko graduated from the Saratov State Medical University (Russia) in 1998 and then he moved to Belgium, where, in 2006, he obtained the Ph.D. degree from the Ghent University (Belgium). Dr. Krysko worked as a FWO Postdoctoral Scientist in the lab of Prof. Vandenabeele (VIB-Ghent University). From October 2016 Dr. Krysko has been appointed as Associate Professor at the Department of Basic Medical Sciences at Faculty of Medicine and Heath Sciences in Ghent University and a group leader of the CRIG (Cancer Research Institute Ghent). Dr. Krysko received several awards for his scientific work and serves as an Editorial Board Member of “Apoptosis” and “Mediators of Inflammation”. He published more than 60 articles in peer-reviewed international journals.
J.L. Li University of Plymouth Plymouth UK Biography
Biography of J.L. Li
Ji-Liang Li is a full professor and chair in Cancer Immunology in Plymouth
University Faculty of Medicine & Dentistry (PUFoMD), UK. He studied Medicine
and had his postgraduate training with Master of Medicine from Sun Yat-Sen
University in 1986. He received his PhD from London University London School of
Hygiene and Tropical Medicine in 1997 and experienced as Postdoctoral Research
Associate in Department of Biochemistry at University of Oxford from 1996-1999,
Research Fellow at Imperial Cancer Research Fund from 1999-2002, Tenured Staff
Scientist/Deputy Lab Head in Cancer Research UK from 2002 to 2007, and then
Tenured Scientist/Deputy Lab Head in Weatherall Institute of Molecular Medicine
at University of Oxford from 2007-2015 prior to take the chair position at
PUFoMD. Prof Li has published more than 80 peer-reviewed papers with a H-
factor of 47. He services as an editor/editorial board member for a dozen of
international journals. His main fields of interests are within tumour
microenvironment and its role in tumour invasion and metastasis, target and
optimal therapies, and their translational medicine.
D. Liao University of Florida College of Medicine Gainesville, FL USA Biography
Biography of D. Liao
Daiqing Liao, Ph.D., conducted his postdoctoral training at Yale University School of Medicine and is currently an Associate Professor at University of Florida College of Medicine and a member of UF Health Cancer Center. The research in his laboratory focuses on cancer epigenetics, metabolism, and signaling pathways as well as development of small molecule therapeutics targeting lysine acetyltransferases (HATs), deacetylases (HDACs), and metabolism for cancer therapy.
J. Lunec University of Newcastle upon Tyne Newcastleupon Tyne UK
A. Macrì University of Messina Messina Italy Biography
Biography of A. Macrì
Antonio Macrì is Associate Professor of Surgery at University of Messina and, on December 16, 2013 has obtained the national scientific enabling at the functions of Full Professor of Surgery. Over the last 25 years, he has focused his scientific interests on the topics related to the abdominal oncology and, in the last 15 years, his principal field of research has became the treatment of peritoneal surface malignancies. He is responsible of the “Peritoneal Surface Malignancies and Sarcoma Program” of the University Hospital Medical School of Messina.
F.M. Marincola Clinical Center, NIH Bethesda, MD USA
M.J. Mckeage University of Auckland Auckland New Zealand
M. Mita Cedars-Sinai Medical Center Los Angeles, CA USA Biography
Biography of M. Mita
Dr. Monica M. Mita is a medical oncologist in Los Angeles, California and is affiliated with multiple hospitals in the area, including Cedars-Sinai Medical Center, Los Angeles, CA, USA, and UCLA Medical Center, Santa Monica, CA, USA. She received her medical degree from Carol Davila University of Medicine and Pharmacy and has been in practice for more than 20 years. She is currently co-director of the Experimental Therapeutics Program at the Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, USA. Her main research focus is on phase I clinical trials in oncology, novel drugs, and targeted therapies, with more than 50 peer-reviewed articles published. In addition, her clinical areas focus on breast cancers and sarcomas.
H. Mukhtar University of Wisconsin-Madison Madison, WI USA
R. Narayanan Florida Atlantic University Boca Raton, FL USA Biography
Biography of R. Narayanan
Ramaswamy Narayanan earned his Ph.D. in biochemistry in 1980 from the National University of Dublin, Ireland. He has worked at the NCI, CDC, the Yale University, Memorial Sloan Kettering Cancer Center, and at the Hoffmann-La Roche, Inc. He has published over 140 peer-reviewed publications and numerous book chapters. He is a Professor at Florida Atlantic University for the last seventeen years, where his work has led to two issued patents and the first Biotech spin-off company for the University. His research revolves around the genomics of cancer and other diseases.
K. Nath University of Pennsylvania Philadelphia, PA USA Biography
Biography of K. Nath
Kavindra Nath is a Research Assistant Professor at the University of Pennsylvania, Perelman School of Medicine, Department of Radiology, Molecular Imaging Laboratory. He did his M.S. in Biochemistry, and Ph.D. in Magnetic Resonance Imaging and Spectroscopy (MRI/MRS). In Ph.D. His current research at University of Pennsylvania is utilizing multi-nuclear (1H, 31P, 13C) MRS and other techniques in vitro and in vivo in order to delineate the mode of action of various monocarboxylate transport (MCTs), mitochondrial pyruvate carrier (MPC) and electron transport chain (ETC) inhibitors, which distinguishes normal cells from malignant cells and potentiates the activities of various chemotherapeutic drugs, hyperthermia and radiation therapy in a variety of human cancers.
V. Notario Georgetown University Medical Center Washington, DC USA
G.H. Reaman Center for Drug Evaluation and Research Washington, DC USA
N.R. Robin University of Auvergne Clermont-Ferrand France Biography
Biography of N.R. Robin
Dr. Nina Radosevic-Robin is presently a Senior Scientist (surgical & molecular pathologist / cell biologist) INSERM U1240, Team 2, Biomarker Group University Clermont Auvergne, Department of Pathology Centre Jean Perrin, Clermont-Ferrand, France. Since 2013, she is also a research instructor (Instruction in research methods, supervision and conception of experiments, scientific and medical publications and presentations Licence) for Master, MD and PhD Programs at University of Auvergne.
R. Roesler Federal University of Rio Grande do Sul Porto Alegre Brazil Biography
Biography of R. Roesler
I am a professor at Daping Hospital and Research Institute of Surgery, Third Military Medical University, China. I received my Ph.D from Seoul National university of Korea. I completed my postdoctoral training in the Department of Molecular Oncology at Moffitt Cancer Center and Research Institute. My research interests include non-coding RNA function in development and progression of cancer and the development and evaluation of novel therapies for cancer.
N. Savaskan University Hospital Erlangen Erlangen Germany Biography
Biography of N. Savaskan
Trained as a developmental neurobiologist, Nicolai Savaskan worked on axon guidance molecules and the PRG family before entering the cancer research field. Trained at the NKI and ETH Zurich, Nic is working on glutamate signalling in brain tumours and angiogenesis. Recently, Nic expanded his research on clinical brain tumour imaging including intraoperative fluorescence and MRi imaging leading to DiVA and vDiVA inventions. Major findings are heterogenic tumour zones in gliomas.
J. Schlom NIH Clinical Center Bethesda, MD USA
A.K. Shamsuddin University of Maryland School of Medicine Baltimore, MD USA Biography
Biography of A.K. Shamsuddin
Dr. AbulKalam M. Shamsuddin is Professor of Pathology at the University of Maryland School of Medicine in Baltimore. He received his medical degree from Dhaka University, and PhD from University of Maryland. He is the pioneering scientist to demonstrate the anti-cancer and immune enhancing function of inositol and inositol hexaphosphate (www.ip-6.net).
Dr. Shamsuddin has published several books, many book-chapters and numerous scientific papers. He serves in the Editorial Board of several cancer related journals; and is a highly sought after speaker in international scientific meetings.
G.V. Sherbet University Newcastle Upon Tyne Newcastle upon Tyne UK
F.A. Sinicrope Mayo Clinic Rochester, MN USA Biography
Biography of F.A. Sinicrope
Frank A. Sinicrope, is Professor of Medicine and Oncology at
Mayo Clinic, Co-leader of the GI cancer program at the Mayo
Clinic Comprehensive Cancer Center, Director for GI Translational
Research for the North Central Cancer Treatment Group legacy
studies, member of the GI Cancer Steering Committee of the
National Cancer Institute, and vice-chair of the Cancer
Prevention Committee and GI Committee of the Alliance for
Clinical Trials in Oncology. Dr. Sinicrope is a board-certified
medical oncologist and gastroenterologist, a recognized leader in
molecular-based risk stratification of colon cancer and conducts
research on experimental therapeutics approaches to reverse
R. Soffietti University of Turin Turin Italy
D.A. Spandidos University of Crete Crete Greece
S.K. Srivastava Texas Tech University Health Sciences Center Abilene, TX USA Biography
Biography of S.K. Srivastava
Dr. Sanjay K. Srivastava is currently a Distinguished Professor and Chair of Department of Immunotherapeutics and Biotechnology specializing in Cancer Biology, Chemoprevention and Therapeutics. He is also the Associate Dean for Sciences. Previously, he was a Professor in the Department of Biomedical Sciences. Prior to his arrival at TTUHSC, Dr. Srivastava served as an Assistant Professor in the Department of Pharmacology, University of Pittsburgh School of Medicine and was a full member of the University of Pittsburgh Cancer Institute. He did his post-doc from the University of Texas Medical Branch at Galveston, Texas. Dr. Srivastava’s research is focused on melanoma, brain cancer, breast cancer, pancreatic cancer, and ovarian cancer and is funded by grants from the National Cancer Institute, NIH. He has authored around 150 research papers and is the Editor of three books. Dr. Srivastava is in the editorial board of several journals and is the member of societies including American Association for Cancer Research, Society of Toxicology and AAPS. He also serves in the grant review panels of National Institute of Health (NIH), Department of Defense and Susan G. Komen Breast Cancer Foundation. His research work has been featured by news agencies including BBC, MSNBC, CBS, ABC, Science News etc.
G.S. Stein University of Massachusetts Medical School Worcester, MA USA
C.F. Stewart St. Jude Children's Research Hospital Memphis, TN USA
P. Storz Mayo Clinic Jacksonville Jacksonville, FL USA Biography
Biography of P. Storz
Peter Storz, Ph.D. is an Associate Professor at the Mayo Clinic. He obtained his Ph.D. from the University of Stuttgart, Germany, and was a postdoctoral fellow and instructor at the Beth Israel Deaconess Medical Center/Harvard Medical School in Boston, before he joined Mayo Clinic. Work in his laboratory focuses on inter- and intracellular signaling that leads to development and progression of pancreatic cancer. Specific interests are to understand the roles of acinar-to-ductal metaplasia and immune cell infiltration in these processes.
S. Stylli The University of Melbourne Melbourne Australia Biography
Biography of S. Stylli
Dr Stanley Stylli is a cancer research scientist at the Department of Neurosurgery, The Royal Melbourne Hospital and an Honorary Fellow of the Department of Surgery (RMH) at The University of Melbourne, Australia. He received his Master of Science and PhD degrees from the University of Melbourne. His research interests include glioma biology, invasion and identifying novel therapeutic targets for glioma. Currently he is investigating the influence of invadopodia in glioma invasion, the response of invadopodia to various therapeutic approaches and the role of tumour-derived exosomes (TEX) for invadopodia biogenesis in glioma.
M.M. Taketo Kyoto University Hospital-iACT Kyoto Japan
P. Workman Institute for Cancer Research Surrey UK
J. Wu University of Oklahoma Health Sciences Center Oklahoma, Ok USA Biography
Biography of J. Wu
Dr. Wu is a Professor in the Department of Pathology and the Peggy and Charles Stephenson Endowed Chair in Cancer Translational Research at the University of Oklahoma Health Sciences Center. Recently, Dr. Wu discovered recurrent JAK1 truncating mutations in endometrial cancer and frequent JAK2 deletion in non-small cell lung cancer (NSCLC) involving tumor immune evasion, and as a potential mechanism of resistance to immune checkpoint therapy. Dr. Wu has authored 80 original research papers plus additional review articles and book chapters. He has served on National Institutes of Health (NIH), NCI, DOD, and Department of Veterans Affairs (VA) grant review panels.
Prof. Guoxiong Xu (MD, PhD) is a Scientist and Director of Center Laboratory in Jinshan Hospital, Fudan University, Shanghai, China. He obtained his PhD degree in Biology from York University in Canada. Dr. Xu is a molecular and cell biologist and has a proven track record on the molecular biology of cancer. He has presented his work in many national and international scientific conferences. His research works are supported by grants from the National Natural Science Foundation of China, Natural Science Foundation of Shanghai, Science and Technology Commission of Shanghai Municipality, and Shanghai Municipal Commission of Health and Family Planning.
P. Xavier-Elsas Federal University of Rio de Janeiro Rio de Janeiro Brazil Biography
Biography of P. Xavier-Elsas
Pedro Xavier-Elsas. Born 03/11/1956, in Rio de Janeiro, Brazil. MD, Federal University of Rio de Janeiro (UFRJ), 1979. Ph.D., Microbiology and Immunology, UFRJ, 1990. Research Fellow, Pathology, Harvard Medical School (HMS), 1981-1983. Research Fellow, Rheumatology/Immunology, HMS/Brigham, 1983-1984. Research Fellow, Centre d’ Immunologie INSERM-CNRS de Marseille-Luminy, France, 1985-1987; Professeur Associé, Université d’Aix-Marseille II, France, 1987-1988. Visiting Scientist, FIOCRUZ, 1989-1990. Professor of Immunology, UFRJ, 1990-2018. Visiting Scientist at the Pasteur Institute, France, 1991, 1997. Visiting Scientist, Roche Research Gent, Belgium, 1994. 2005. Visiting Professor of Medicine, HMS/Brigham 2002-2018, Fellow, Brazilian National Research Council (CNPq). Awardee, FAPERJ, “Rio de Janeiro State Scientists”, 2012-2015.
J. Xiang University of Saskatchewan Saskatoon, SK Canada
C.-X. Xu Third Military Medical University Chongqing China Biography
Biography of C.-X. Xu
I am a professor at Daping Hospital and Research Institute of Surgery, Third Military Medical University, China. I received my Ph.D from Seoul National university of Korea. I completed my postdoctoral training in the Department of Molecular Oncology at Moffitt Cancer Center and Research Institute. My research interests include non-coding RNA function in development and progression of cancer and the development and evaluation of novel therapies for cancer.
P. Zarogoulidis General Hospital Aristotle University of Thessaloniki Thessaloniki Greece Biography
Biography of P. Zarogoulidis
Dr. Paul Zarogoulidis, M.D, MS.c, Ph.D, is a pulmonary physician with expertise in interventional pulmonology and lung cancer treatment. He is a member of CABIP, ERS, ATS, EABIP. He is an associate editor in 3 journals and editor in 14 journals. He has 250 publications on pub med. He has written 3 chapters in 3 books. He is the president of `The Society for Diagnosis and Lung Cancer Treatment`. One of his main interests is the development of novel inhalational drugs and inhalational delivery systems. He is currently working in the Pulmonary Department-Oncology Unit, `’Theageneio’ Anticancer Hospital, Greece and 3 different private hospitals.
Associate Editorial Board Members
P. Gaetano University of Catania Catania Italy Biography
Biography of P. Gaetano
Piccolo Gaetano was born on 23/05/1983 in Catania, Sicily, Italy. M.D, Postgraduate Medical Specialty in General Surgery, PhD at the Department of Surgery, University of Catania. Co-investigator at the IRCCS Mediterranean Institute for Transplantation and High Specialization Therapies - I.S.M.E.T.T- UPMC, for the ITALIVER MULTICENTER STUDY. Systematic collection of cases of hepatocellular carcinoma, intrahepatic cholangiocarcinoma and hilar cholangiocarcinoma undergoing liver resection. Peer Review for: Medical Journal - OMICS Publishing Group, World Journal of Gastroenterology - Number ID 02953899, Annals of Hepatology, Frontiers of Medicine – Springer, BMJ Case Report, Surgical Oncology, World Journal of Surgery. Editorial Board Member for the International Journal of Gastroenterology Disorders & Therapy. Author and Co-author of many publications. SCOPUS (H-Index 11). Scopus Author ID: 54585796900. ORCID ID https://orcid.org/0000-0002-4942-7705.
Dr. Manish Kumar is an Assistant Professor in Botany at S.D. College, Barnala, Punjab, India. Dr. Kumar is M.Sc., M.Phil. & PhD in Botany from Guru Nanak Dev University and has qualified CSIR-NET and GATE. He has over 3 years of teaching and 9 years of research experience and his areas of specialization include Cancer Chemoprevention, Genetic Toxicology, Environmental mutagenesis and Medicinal plants. He has published more than 30 research articles in journals and books of international repute with a cumulative impact factor of more than 35. He has been a member of the editorial board and reviewer board of many journals. He has been recognized for outstanding contribution in Reviewing for the Journal “Journal of Traditional and Complementary Medicine (Elsevier)” in 2017. He has been a member of various national and international conferences/programs. Recently, Dr. Kumar has edited a book with Bentham Science Publishers.
S.K. Mandal Dr. B. C. Roy College of Pharmacy and Allied Health Sciences Durgapur India
S. Nara Motilal Nehru National Institute of Technology Allahabad India Biography
Biography of S. Nara
Dr. Seema Nara is an Associate Professor in Department of Biotechnology, MNNIT Allahabad, India since April 2009. She has completed her doctorate from Indian Institute of Technology Delhi, India in 2009 in the field of Immunodiagnostics. She has been working in the area of developing diagnostic solutions for detecting pathogens, cancer biomarkers, food/environment contaminants using antibodies and aptamers. Her group is actively engaged in exploring the applications of nanostructures diagnostics as well as therapeutics. She has successfully completed extramural projects in the area of her interest. Her research outcome is published in International journals of repute, as book chapters and is also evident from filed 03 patents.
M. Sedic University of Rijeka Rijeka Croatia Biography
Biography of M. Sedic
Dr. Mirela Sedic is Associate Professor at the University of Rijeka Department of Biotechnology in Croatia. She has authored more than 30 scientific publications in peer-reviewed journals including high-impact journals such as Molecular Cancer, The Journal of Pathology, Molecular Cancer Therapeutics, Journal of Medicinal Chemistry, and Cancer Treatment Reviews. She is co-author of book chapters in Bioinformatics and Drug Discovery (Humana Press, 2012), Personalized Medicine: A New Medical and Social Challenge (Springer International Publishing, 2016), and has one international patent (WO/2010/052510). Her main research interests include cancer biology and signalling, experimental oncology, chemoresistance, sphingolipids in cancer and proteomics.
N.G. Yousif Al Muthanna Medical School/Al Muthanna University Muthanna Iraq Biography
Biography of N.G. Yousif
Nasser Ghaly Yousif, MD, MSc, Postdoctoral fellow, is a graduate of Basrah University Medical College/Iraq. He trained in internal medicine at the University of Colorado and Oncology hematology at Ulm teaching hospital/Germany and the University of Colorado/USA. Yousif recently received the first prize of Iraqi Science day 2016/Ministry of Higher Education and Scientific Research, beside other wards: MD-Anderson Prize/USA 2015, Travel grant, shock meeting/USA 2014, Travel grant, ASCO meeting 2014, Travel grant, ESMO conference/Italia 2013. Nasser Ghaly Yousif has published more than 30 paper researches in high quality Journals and revised more than 70 research manuscripts for high impact factor journals.
Executive Guest Editors
N. Autsavapromporn Chiang Mai University Chiang Mai Thailand Biography
Biography of N. Autsavapromporn
Dr. Autsavapromporn received his Ph.D. degree in Radiobiology from University of Sherbrooke, Canada
in 2011. He has completed his training as a Post-doc fellow under the Japan Society for the Promotion of
Science Fellowship in National Institute of Radiological Sciences, Japan from 2011 to 2013. He was
horned by the International Nuclear Science and Technology Conference in 2019 with the prize “Nuclear
Scientist Award”. Currently, he is an Assistant Professor of Radiation Oncology in Faculty of Medicine,
Chiang Mai University, Thailand. His research interests mainly focus on radiobiological effect of proton
and heavy ions, biomarker of lung cancer, biodosimetry and radioecology.